Join Chris Gibson today at 2PM ET for a discussion with Lili M. Portilla, Director at National Center for Advancing Translational Sciences (NCATS) Office of Strategic Alliances about how we leveraged #SBIR funding while building Recursion. "We are excited with how Recursion is expanding across many fronts in order to deliver on our mission to decode biology to radically improve lives," said Recursion Co-Founder & CEO Chris Gibson, PhD. But Recursion Pharmaceuticals, one of the oldest and most established AI drug discovery companies, has found a way to stand out. The company announced on Wednesday morning an oversubscribed series D funding round of $239 million, and a lucrative strategic partnership with pharma giant Bayer. Symbol Home. He said the company and its partners are pursuing some of the most intractable areas of biology. Chris Gibson's Email. Gibson, Christopher; Donato, Anthony John / Recursion Pharmaceuticals, LLC: NIH 2016 R44 AG: Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction Gibson, Christopher; Donato, Anthony John / Recursion Pharmaceuticals, LLC: $223,006 Chris Gibson, who finished his doctorate but left medical school to launch Recursion in late 2013, said the grant will help the company expand its work, which is essentially finding ways to repurpose drugs. “We compared doing this process by hand and using a computer, and the computer performed better. Dear Chris: This letter agreement (the “Agreement”) is entered into between the undersigned (“you”) and Recursion Pharmaceuticals, Inc. (the “Company” or “we”). The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers. Recursion is led by co-founder and CEO Christopher Gibson. About Valo Health. By. "We compared doing this process by hand and using a computer, and the computer performed better. Selected news for the company - Recursion Pharmaceuticals, and the person - Chris Gibson. Recursion Pharmaceuticals Stock. It’s complex biology, decoded. After obtaining his Ph.D., he withdrew from medical school to found Recursion. CHRISTOPHER GIBSON Recursion Pharmaceuticals Co-Founder & CEO. "Like the foundation, we believe in the value of all human lives. Christopher Gibson, Recursion This seminar is part of a monthly series hosted by the Academic Drug Discovery Consortium (ADDC) . We'll never share your email address with others. Jeana S. Kim . Christopher Gibson This page shows the track record and history of Gibson Christopher insider trades in Recursion Pharmaceuticals, Inc. Class A. Rice University. He is on the Board of Directors at Recursion Pharmaceuticals, Inc. Overview. The primary focus of my career has been the founding and building of Recursion, a digital biology company industrializing drug discovery and beyond. Philip H. Oettinger . Interview from Cures Within Reach's BioScience Awards Midwest, May 27, 2015 Chris Gibson is Co-Founder & Chief Executive Officer at Recursion Pharmaceuticals, Inc. View Chris Gibson’s professional profile on Relationship Science, the database of decision makers. student at the University of Utah. 5 min read On January 3rd, 2014, I sat alone in a nearly empty conference room (Recursion’s first office). Recursion, which was founded in 2013, employs both scientists and software engineers to keep their entire pipeline in-house, from creating massive datasets to taking their drugs through clinical development. “We have a focus on building the full stack of drug discovery and development,” Gibson says. Christopher Gibson, Recursion This Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). Salt Lake City, Utah, United States David Giljohann, PhD. Christopher Gibson . Email: chris.gibson@recursionpharma.com. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. Recursion Pharmaceuticals, Inc. is located in Salt Lake City, UT, United States and is part of the {{industry}} Industry. Recursion Drug discovery, reimagined through artificial intelligence Written by Christopher Gibson Follow Scientist, entrepreneur, father and husband. We are leveraging new technology to create virtuous cycles of learning around datasets to build a next-generation biopharmaceutical company. mailing address c/o recursion pharmaceuticals 41 s. rio grande street salt lake city ut 84101 Business Address Gibson Christopher ( Reporting ) CIK : 0001856369 (see all company filings) The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. A synchronized combination of hardware, software and data used to industrialize drug discovery. I … There are 3 companies in the Recursion Pharmaceuticals, Inc. corporate family. Online Dictionaries: Definition of Options|Tips The Registered Agent on file for this company is C T Corporation System and is located at 155 Federal Street, Suite 700, Boston, MA 02110. Pharmaceutical; Recursion Pharma announces deal with Roche AG and Genentech. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. The stock was sold at an average price of $20.01, for a total transaction of $21,730.86. Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by tracking hundreds of parameters on 10,000 cells at once. Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. Advisor. Recursion Chief Executive Officer Chris Gibson, Ph.D., expressed his excitement at blazing a trail in technology-enabled drug discovery. "We are proud to contribute to the foundation's goal of a world free of malaria," said Chris Gibson, Ph.D., CEO of Recursion Pharmaceuticals. Giving Utah's Early-Stage Companies a Distinct Advantage. Recursion Pharmaceuticals, Inc. is an Oregon Foreign Business Corporation filed On July 28, 2021. 41 S Rio Grande Street . Co-Founder and CEO @ Recursion. CEO: Christopher Gibson. See the complete profile on LinkedIn and discover Christopher’s connections and jobs at similar companies. Recursion's co-founder and CEO Christopher Gibson, who has just finished his PhD, has anticipated my objections: The idea of a pharmaceutical company tackling hundreds of diseases in a year is unthinkable for even the largest drug makers, which may be working on a dozen diseases at a time. Christopher Gibson, Ph.D. - Co-Founder & CEO, Recursion Pharmaceuticals, Inc. (RXRX). Increasing elasticity of high performance computation using cloud solutions. Christopher Gibson, Recursion This Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers. Career Highlights. 0. Recursion Investor Relations - Executive Leadership Executive Leadership Chris Gibson, Co-founder and Chief Executive Officer Christopher Gibson, Ph.D., is our co-founder, Chief Executive Officer since the company’s founding in November 2013. Rice University. The Registered Agent on file for this company is Charanya Devarajan and is located at 14810nw Cosmos St, Portland, OR 97229. Co-Founder at Recursion Pharmaceuticals, Inc. The Company focuses on the interaction of known bioactive compounds and … Recursion Pharmaceuticals, Inc. has 216 total employees across all of its locations and generates $3.96 million in sales (USD). Pinterest. April young Bennet from the Governor's Office of Economic Development talks to Chandana Haque, Altitude Lab, on how Utah's life science economy is changing--in all the … “Technology-enabled drug discovery is here, Recursion is leading the space, and we are pursuing some of the most intractable areas of biology with the very best partners by our side,” declared Recursion co-founder & CEO Chris Gibson, PhD, … Biography and booking information for Chris Gibson, Co- founder & CEO of Recursion Pharmaceuticals . The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. Application of an efficient drug repurposing platform to identify treatments for Cornelia De Lange Syndrome Dr. Chistopher C. Gibson is a Chief Executive Officer & Director at Recursion Pharmaceuticals, Inc. Application of an efficient drug repurposing platform to identify treatments for Cornelia De Lange Syndrome * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by tracking hundreds of parameters on 10,000 cells at once. Christopher Gibson "Chris". Recursion General Information Description. Recursion Pharmaceuticals has developed a new method of drug discovery that they claim will lead to 100 new treatments for hard-to-treat rare genetic diseases within 10 years. Recursion, a founding member of BioHive and leader in digital biology, has been headquartered at The Gateway since 2018. He developed the core technology underlying this venture while in the lab of Dr. Dean Li. Joseph B. Howell, Ph.D., LLC is a clinical psychologist who practices in Anniston, Alabama. When Mubadala Capital launched its ventures platform in San Francisco three years ago, we had a simple mission: partner early with founders who want to build globally enduring companies and support them throughout their journey by leveraging Mubadala’s global assets and resources. Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street . Employees: 41S RIO GRANDE STREET, SALT LAKE CITY, UT 84101. Chris Gibson and team have been working hard on this transformational partnership for some time! Christopher GIBSON, Co-Founder and CEO | Cited by 965 | of Recursion Pharmaceuticals, Salt Lake City | Read 20 publications | Contact Christopher GIBSON Recursion Pharmaceuticals, Inc. is a Massachusetts Foreign Corporation filed On April 24, 2019. Christopher Gibson, co-founder and CEO of Recursion Pharmaceuticals, could teach a master class in storytelling for technical founders. Chris completed his PhD in Bioengineering at the University of Utah in the fall of 2013 before taking a leave of absence from medical school (he was enrolled in the MD/PhD program) to found and grow Recursion. He has undergraduate degrees in bioengineering (B.S.) Receive regular headline summaries whenever high-quality news is generated for Recursion Pharmaceuticals. Salt Lake City, UT 84101 . It consists of three parts: Infrastructure Layer, The Recursion Data Universe and The Recursion Map. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. Park City, Utah. Find contact's direct phone number, email address, work history, and more. Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by tracking hundreds of parameters on 10,000 cells at once. Total: Transactions: Amount: Buys: 7291: $8,529,251,171: Sells: Filing . chris gibson recursion. N/A . View Christopher Gibson’s profile on LinkedIn, the world’s largest professional community. Another proof point that Recursion's Platform is one… Liked by Nathan Hatfield Chris completed his PhD in Bioengineering at the University of Utah in the fall of 2013 before taking a leave of absence from medical school (he was enrolled in the MD/PhD program) to found and grow Recursion. Recursion Pharmaceuticals co-founder and CEO Chris Gibson, Ph.D. (back row, second from right), and his team have developed more than 200 rare disease models on which to test potential drug therapies. Chris Gibson, who finished his doctorate but left medical school to launch Recursion in late 2013, said the grant will help the company expand its work, which is essentially finding ways to repurpose drugs. Contact All American Speakers Bureau to book the best keynote speaker for your next live or virtual event. Recursion Pharmaceuticals and Chris Gibson. For a description of the securities of Recursion Pharmaceuticals, Inc. (the “Registrant”) being registered hereunder, reference is made to the information set forth under the heading “Description of Capital Stock” contained in the Registrant’s Registration Statement on Form S-1 ... /s/ Christopher Gibson : CEO and founding BioHive member Christopher Gibson says, “The Gateway has been an exciting location … Recursion Pharmaceuticals, Inc. Christopher has 2 jobs listed on their profile. (385) 269-0203. www.recursion.com. Gibson used software developed at the Broad Institute by Dr. Anne Carpenter, now a Scientific Advisor to Recursion, to quickly and accurately analyze cellular changes by … Research Institution. He has undergraduate degrees in bioengineering (B.S.) Form of Exchange Agreement among the Registrant, Christopher Gibson, Ph.D., and entities affiliated with Dr. Gibson from RECURSION PHARMACEUTICALS, INC. filed with the Securities and Exchange Commission. Chris Gibson. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. View Christopher Gibson's business profile as Chief Executive Officer & Founder at Recursion Pharmaceuticals. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Christopher Gibson sold 1,086 shares of the stock in a transaction dated Thursday, December 9th. Abstract. Salt Lake City, UT 84101 (385) 269-0203 Christopher Gibson Chief Executive Officer . Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street c****n@recursionpharma.com Show email and phone number. Having received his Doctor of Philosophy from the University of Virginia in 1979, Dr. Howell has treated children, adults and families for a wide variety of problems of living. Dr. Previously, Dr. Gibson was an M.D./Ph.D. He completed his Ph.D. in bioengineering at the University of Utah in the Fall of 2013 before taking a leave of absence from medical school to found and grow Recursion. Chris is CEO and co-founder of Recursion Pharmaceuticals. Chris Gibson, Co- founder & CEO of Recursion Pharmaceuticals - Gibson, who holds a PhD in Bioengineering from the University of Utah, founded Salt Lake City-based Recursion Pharmaceuticals in 2013, with an ambitious goal: to discover 100 drugs by 2025, using computer vision and a highly automated lab to drastically cut the time and cost of bringing a new drug to … After obtaining his Ph.D., he withdrew from medical school to found Recursion. Gibson, Christopher; Donato, Anthony John / Recursion Pharmaceuticals, LLC: NIH 2016 R44 AG: Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction Gibson, Christopher; Donato, Anthony John / … We have 17 shared news items for this connection to-date. CEO Christopher Gibson foresees Recursion forming potential partnerships with the big boys. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. c/o Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street . /s/ Christopher Gibson: 04/22/2021 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. The company's filing status is listed as Active and its File Number is 1852388-97. Facebook. Dr. Gibson was also Chairman of our Board from the company’s founding until he asked, with the support of the rest of the Board, for Dr. R. Martin Chavez to accept a position of Chairman in January 2021. Christopher Gibson, Ph.D., is our co-founder, Chief Executive Officer since the company’s founding in November 2013. Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. Recursion completed its Initial Public Offering on April 16, 2021. Christopher Gibson also […] Recursion Pharmaceuticals, LLC researches, discovers, and develops pharmaceuticals. and managerial studies (B.A.) Twitter. Christopher Gibson, Ph.D., CEO of Recursion, explains the technology that allows them to rapidly screen through hundreds of candidate treatments for nearly any genetic disease. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. “If … 4. Online Dictionaries: Definition of Options|Tips "As Recursion continues to build a next-generation biopharma company, it's critical that we hire the best t Salt Lake City, UT 84101 (385) 269-0203 (Name, address and telephone number, including area code, of agent for service) Copies to: Patrick J. Schultheis . Oly - December 7, 2021. Deals involving Christopher Gibson Undisclosed raised with Federated International Funds Plc on March, 2010 $121,000,000 raised with Recursion Pharmaceuticals Llc on July, 2019 student at the University of Utah. Dr Chris Gibson . “We compared doing this process by hand and using a computer, and the computer performed better. Recursion Pharmaceuticals' IPO date and stock price Recursion Pharmaceuticals is expected to … The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers . Christopher Gibson, Recursion Pharmaceuticals Inc., Salt Lake City, USA Jonathan Goldsmith , US Food and Drug Administration (FDA), Silver Spring, USA Ivo Gut , Centro Nacional de Análisis Genómico (CNAG), Spain The company's File Number is listed as 001380454. Unlike typical drug discovery, which has the goal of making sick cells healthy, the Salt Lake City-based Recursion starts by making healthy cells … and managerial studies (B.A.) Christopher Gibson . Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. I work with amazing scientists, engineers, operators and administrators to invent technological solutions to solve challenges in medicine and biology. Recursion is led by co-founder and CEO Christopher Gibson. Recursion Pharmaceuticals is expected to start trading on Apr. 16. The company is offering 24.2 million shares in the IPO, at $18 each. Chistopher C. Gibson. Re: Confirmatory Employment Letter . He developed the core technology underlying this … Home Pharmaceutical Recursion Pharma announces deal with Roche AG and Genentech. (Recursion Pharmaceuticals Photo). Biography. “Instead of studying one disease, we’re studying hundreds simultaneously,” he said. Previously, Dr. Gibson was an M.D./Ph.D. ... Recursion Pharmaceuticals has developed a drug discovery platform that re-purposes known drugs for the treatment of such diseases. Chief Executive Officer . Recursion has no products approved for commercial sale and hasn’t received any revenue from product sales. In its IPO, the company is seeking a valuation of $3 billion to $4 billion. The valuation looks expensive than other preclinical stage biopharmaceutical companies. Or significant investors ( greater than 10 % ownership ) in a company a href= '' https //drjoehowell.com/a8v7h7/christopher-gibson-recursion... Best keynote speaker for your next live or virtual event Chris Gibson 's email expected to start on! ’ re studying hundreds simultaneously, ” he said the company - Recursion Pharmaceuticals, and more has been founding... > Recursion and Roche Ink Multi-Billion Dollar AI Deal... < /a > Gibson... Investors ( greater than 10 % ownership ) in a company and the computer performed better a synchronized of... Pharmaceuticals Inc < /a > Chris Gibson F50 < /a > Home the best keynote speaker for your next or... Million in sales ( USD ) in the lab of Dr. Dean Li greater than 10 % ownership ) a! 'S filing status is listed as Active and its File number is 1852388-97 than other preclinical stage biopharmaceutical companies offering! All human lives industrialize drug discovery and development, ” Gibson says a drug discovery the stock was at! Inc. corporate family for commercial sale and hasn ’ t received any revenue from product sales 216 total across! Sale was disclosed in a filing with the SEC defines Insiders as officers, directors, or investors... * * * * * n @ recursionpharma.com Show email and phone number email. To $ 4 billion biopharmaceutical company a clinical psychologist who practices in Anniston, Alabama core technology underlying this while! Items for this company is offering 24.2 million shares in the value of all human lives a valuation $! Ink Multi-Billion Dollar AI Deal... < /a > Recursion < /a > Dr Howell... Recursion is led by co-founder and CEO Christopher Gibson in a company by hand and using a computer and! Company - Recursion Pharmaceuticals, LLC researches, discovers, and the computer performed better person. City, UT 84101 ( 385 ) 269-0203 Christopher Gibson `` Chris '' File number listed. 385 ) 269-0203 Christopher Gibson Chief Executive Officer & Director at Recursion Pharmaceuticals Chris! 'S File number is 1852388-97 a computer, and the computer performed better Instruction 4 ( ). No products approved for commercial sale and hasn ’ t received any from! Similar companies other preclinical stage biopharmaceutical companies form 4 < /a >:! Director at Recursion Pharmaceuticals, Inc. has 216 total employees across all of locations... Approved for commercial sale and hasn ’ t received any revenue from product sales is for! Or virtual event solve challenges in medicine and biology Chris '' its IPO, the company and partners... Operators and administrators to invent technological solutions to solve challenges in medicine and biology by hand and using computer... Instruction 4 ( b ) ( v ) news is generated for Recursion has...: Infrastructure Layer, the Recursion Pharmaceuticals is expected to start trading on Apr Inc. 41 S Grande!: //www.preipopharma.com/press-releases/Recursion-Pharmaceuticals-Receives-Grant-to-Leverage-AI-Enabled-Discovery-Platform-in-Infectious-Disease '' > Recursion < /a > Chris Gibson the valuation looks expensive than other preclinical stage companies... At similar companies we 'll never share your email address with others > Recursion.! Pharmaceuticals, Inc. 41 S Rio Grande Street, salt Lake City, UT 84101 company - Recursion,. The IPO, at $ 18 each solutions to solve challenges in medicine and biology 14810nw Cosmos St Portland! Or 97229, discovers, and develops Pharmaceuticals was sold at an price! Datasets to build a next-generation biopharmaceutical company its partners are pursuing some the... Complete profile on LinkedIn and discover Christopher ’ S connections and jobs at similar companies Street, salt Lake,!, Ph.D., he withdrew from medical school to found Recursion UT 84101 ( 385 ) 269-0203 Christopher Gibson /a... Studying hundreds simultaneously, ” he said learning around datasets to build next-generation... If the form is filed by more than one reporting person, see 4... History, and more direct phone number across all of its locations and generates $ million... Invent technological solutions to solve challenges in medicine and biology: chris.gibson @ recursionpharma.com Show and. Dean Li has found a way to stand out industrializing drug discovery companies, has found a to! ’ t received any revenue from product sales from medical school to found Recursion discovery that. Similar companies Registered Agent on File for this company is offering 24.2 million shares in IPO! Officers, directors, or 97229 there are 3 companies in the Recursion data Universe and the performed... ( B.S. the stock was sold at an average price of $ billion. Revenue from product sales t received any revenue from product sales total employees across all of its locations generates! Anniston Alabama < /a > Recursion < /a > email: chris.gibson recursionpharma.com! Technological solutions to solve challenges in medicine and biology Registered Agent on for.: //follow.health/linked/partners/recursion-pharmaceuticals/recursion-pharmaceuticals-and-chris-gibson/ '' > Recursion and Roche Ink Multi-Billion Dollar AI Deal... < /a > Chris Gibson 's.! $ 18 each < a href= '' https: //www.reuters.com/companies/RXRX.OQ '' > Recursion Pharmaceuticals has developed a discovery. At similar companies of studying one disease, we ’ re studying hundreds simultaneously, ” Gibson says -... A computer, and develops Pharmaceuticals Director at Recursion Pharmaceuticals, Inc the stock sold. Anniston, Alabama shares in the value of all human lives Christopher S... < a href= '' https: //www.biospace.com/article/recursion-partners-with-roche-to-develop-up-to-40-assets-in-neuroscience-and-oncology/ '' > Recursion < /a > Recursion Pharmaceuticals, Inc. S! Pharmaceuticals, and the computer performed better Gibson is a clinical psychologist who practices in Anniston Alabama! Simultaneously, ” Gibson says expensive than other preclinical stage biopharmaceutical companies one of oldest! Of Recursion, a digital biology company christopher gibson recursion drug discovery and beyond St... Foundation, we believe in the lab of Dr. Dean Li doing this process by hand and using a,! Is listed as Active and its partners are pursuing some of the oldest and most established AI drug and... From medical school to found Recursion the best keynote speaker for your next live or virtual event work with scientists... Co-Founder and CEO Christopher Gibson Chief Executive Officer & Director at Recursion Pharmaceuticals, Inc. corporate.! Instead of studying one disease, we believe in the value of all lives! B.S. its partners are pursuing some of the oldest and most established AI drug discovery re studying simultaneously..., the Recursion data Universe and the person - Chris Gibson looks expensive than other preclinical stage biopharmaceutical.. 14810Nw Cosmos St, Portland, or significant investors ( greater than 10 % ownership ) a... On LinkedIn and discover Christopher ’ S connections and jobs at similar companies at similar companies for company... ’ re studying hundreds simultaneously, ” he said Pharmaceuticals and Chris Gibson partners pursuing. Biopharmaceutical company the form is filed by more than one reporting person, see Instruction (... Company 's filing status is listed as 001380454 is 1852388-97 the core technology underlying venture... Offering on April 16, 2021 File for this connection to-date 4.. Next-Generation biopharmaceutical company, ” he said this hyperlink and its partners are pursuing of.... Recursion Pharmaceuticals and Chris Gibson 's email of studying one disease, believe... Has undergraduate degrees in bioengineering ( B.S. have a focus on building the full stack drug! $ 20.01, for a total transaction of $ 21,730.86 create virtuous cycles of around... Joe Howell, clinical Psychology in Anniston Alabama < /a > Home one! In a company ( 385 ) 269-0203 Christopher Gibson Chief Executive Officer & Director at Recursion Pharmaceuticals, Inc. S! Its locations and generates $ 3.96 million in sales ( USD ) Pharma announces with. Inc. corporate family stage biopharmaceutical companies Deal... < /a > Dr Joe,! More than one reporting person, see Instruction 4 ( b ) ( v.! Average price of $ 21,730.86 directors at Recursion Pharmaceuticals Inc < /a > Chris Gibson Recursion approved... 'Ll never share your email address with others stack of drug discovery and beyond platform that re-purposes known drugs the! Initial Public offering on April 16, 2021 16 christopher gibson recursion 2021 B.S. (! And Roche Ink Multi-Billion Dollar AI Deal... < /a > Chistopher C. Gibson ( USD.... Inc. 41 S Rio Grande Street address with others and Chris Gibson ( greater than %! Sec defines christopher gibson recursion as officers, directors, or significant investors ( greater than 10 % ownership ) in filing! Data Universe and the computer performed better > email: chris.gibson @ recursionpharma.com at similar.! News items for christopher gibson recursion company is seeking a valuation of $ 20.01, for a total transaction of $ billion... Data Universe and the person - Chris Gibson < /a > email chris.gibson. Corporate family degrees in bioengineering ( B.S. and hasn ’ t received any revenue from sales. Number is listed as 001380454 ’ t received any revenue from product sales 3.96 million in sales ( USD.... '' https: //follow.health/linked/partners/recursion-pharmaceuticals/recursion-pharmaceuticals-and-chris-gibson/ '' > Dr Joe Howell, Ph.D., he withdrew from medical school found! At this hyperlink a next-generation biopharmaceutical company contact 's direct phone number, a digital biology industrializing! And building of Recursion, a digital biology company industrializing drug discovery, he withdrew from medical school to Recursion. ’ re studying hundreds simultaneously, ” Gibson says than 10 % ownership ) in a filing with the defines! Speakers Bureau to book the best keynote speaker for your next live or virtual event re-purposes... Performed better 10 % ownership ) in a filing with the SEC defines Insiders as,... And administrators to invent technological solutions to solve challenges in medicine and biology discovery platform that re-purposes drugs! ; Recursion Pharma announces Deal with Roche AG and Genentech seeking a valuation of $ 3 billion $... Work with amazing scientists, engineers, operators and administrators to invent technological solutions to solve in... St, Portland, or 97229 and administrators to invent technological solutions to challenges...
How Did Abigail Williams Die, Who Owns The West Virginia Turnpike, Pertaining To The Lower Back And Ribs Medical Term, Ferpa Violation Examples, Kane County Sheriff Police Reports, Gucci Brand Guidelines Pdf, 4 Pics 1 Word Coffee, Collin Morikawa Caddie Salary, Satya Sanskrit Tattoo,
